+

WO2001077126A3 - Haplotypes du gene hsd3b2 - Google Patents

Haplotypes du gene hsd3b2 Download PDF

Info

Publication number
WO2001077126A3
WO2001077126A3 PCT/US2001/011707 US0111707W WO0177126A3 WO 2001077126 A3 WO2001077126 A3 WO 2001077126A3 US 0111707 W US0111707 W US 0111707W WO 0177126 A3 WO0177126 A3 WO 0177126A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsd3b2
gene
haplotypes
delta
disclosed
Prior art date
Application number
PCT/US2001/011707
Other languages
English (en)
Other versions
WO2001077126A2 (fr
Inventor
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, Anne Chew, Julie Y Choi, Beena Koshy, J Claiborne Stephens filed Critical Genaissance Pharmaceuticals
Priority to AU2001251524A priority Critical patent/AU2001251524A1/en
Publication of WO2001077126A2 publication Critical patent/WO2001077126A2/fr
Publication of WO2001077126A3 publication Critical patent/WO2001077126A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouveaux polymorphismes mononucléotidiques dans le gène humain Hydroxy-delta-5-stéroïde déshydrogénase, 3 bêta- et stéroïde delta-isomérase (HSD3B2). En outre, elle porte sur divers génotypes, haplotypes et paires d'haplotype pour le gène HSD3B2 qui existent dans la population. Elle traite également de compositions et de procédés d'haplotypage et/ou de génotypage du gène HSD3B2 chez un individu. Elle concerne enfin des polynucléotides contenant au moins un polymorphisme HSD3B2.
PCT/US2001/011707 2000-04-10 2001-04-10 Haplotypes du gene hsd3b2 WO2001077126A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001251524A AU2001251524A1 (en) 2000-04-10 2001-04-10 Haplotypes of the hsd3b2 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19577500P 2000-04-10 2000-04-10
US60/195,775 2000-04-10

Publications (2)

Publication Number Publication Date
WO2001077126A2 WO2001077126A2 (fr) 2001-10-18
WO2001077126A3 true WO2001077126A3 (fr) 2002-05-16

Family

ID=22722752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011707 WO2001077126A2 (fr) 2000-04-10 2001-04-10 Haplotypes du gene hsd3b2

Country Status (2)

Country Link
AU (1) AU2001251524A1 (fr)
WO (1) WO2001077126A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] October 2000 (2000-10-01), PENG ET AL.: "Homo sapiens cDNA clone ADBBGG07 5', mRNA sequence", XP002906661, accession no. EST Database accession no. AV704637 *
HENDERSON ET AL.: "Hormonal carcinogenesis", CARCINOGENESIS, vol. 21, no. 3, March 2000 (2000-03-01), pages 427 - 433, XP002906660 *
MOISAN ET AL.: "New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 84, no. 12, pages 4410 - 4425, XP002944253 *
YAMADA ET AL.: "Identification of 142 single nucleotide polymorphisms in 41 candidate genes for rheumatoid arthritis in the Japanese population", HUMAN GENETICS, vol. 106, March 2000 (2000-03-01), pages 293 - 297, XP002947356 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
AU2001251524A1 (en) 2001-10-23
WO2001077126A2 (fr) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001077126A3 (fr) Haplotypes du gene hsd3b2
WO2001079228A3 (fr) Haplotypes du gene f12
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001077128A3 (fr) Haplotypes du gene slc5a3
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001077125A3 (fr) Haplotypes du gene ccr5

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载